Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP
Mankind Pharma’s stock increased 2.3% during trading, reaching an intraday high of Rs 2,753 on the BSE. A day after the company’s qualified institutional placement (QIP) was launched, the stock was purchased at a floor price of Rs 2,616.55 per share. This is a 2.4% reduction from the closing price on Monday. According to its […]
Mankind Pharma shares in focus after co launches Rs 3,000 crore QIP Read More »